Purple Biotech Ltd. (PPBT)
0.633
-0.02
(-2.62%)
USD |
NASDAQ |
Jan 16, 16:00
0.6202
-0.01
(-2.02%)
After-Hours: 20:00
Purple Biotech Shareholders Equity (Quarterly): 32.77M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Compugen Ltd. | 43.83M |
| Can-Fite BioPharma Ltd. | -- |
| BiomX, Inc. | 10.49M |
| Nasus Pharma Ltd. | -- |
| Regentis Biomaterials Ltd. | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 39.06M |
| Total Liabilities (Quarterly) | 6.246M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 1.779 |
| Net Debt Paydown Yield | 0.02% |